DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes

Nucleic Acids Research

Volumn 44, Issue 11, 2016, Pages 5161-5173

  Choi, Si Ho ^a,b   Gearhart, Micah D ^c   Cui, Ziyou ^a   Bosnakovski, Darko ^a   Kim, Minjee ^b   Schennum, Natalie ^a   Kyba, Michael ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Dongnam Institute of Radiological and Medical Science   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBP PROTEIN; DUX4 PROTEIN; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE H3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DUX4 PROTEIN, HUMAN; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; HOMEODOMAIN PROTEIN; PROTEIN BINDING;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; DUX4 GENE; GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; MASS SPECTROMETRY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSGENE; ZSCAN4 GENE; ACETYLATION; CELL LINE; CHEMISTRY; EPIGENETICS; GENE EXPRESSION; GENETIC EPIGENESIS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PROCEDURES; PROMOTER REGION; REPORTER GENE;

ACETYLATION; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION; GENES, REPORTER; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; MYOBLASTS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION, GENETIC;

EID: 84976350870     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw141     Document Type: Article

References (35)

1. Gabellini, D., Green, M.R., and Tupler, R. (2002) Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell, 110, 339-348.
2. Zeng, W., de Greef, J.C., Chen, Y.Y., Chien, R., Kong, X., Gregson, H.C., Winokur, S.T., Pyle, A., Robertson, K.D., Schmiesing, J.A. et al. (2009) Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet., 5, e1000559.
3. van Overveld, P.G., Lemmers, R.J., Sandkuijl, L.A., Enthoven, L., Winokur, S.T., Bakels, F., Padberg, G.W., van Ommen, G.J., Frants, R.R., and van der Maarel, S.M. (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet., 35, 315-317.
4. de Greef, J.C., Lemmers, R.J., van Engelen, B.G., Sacconi, S., Venance, S.L., Frants, R.R., Tawil, R., and van der Maarel, S.M. (2009) Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum. Mutat., 30, 1449-1459.
5. Wijmenga, C., Hewitt, J.E., Sandkuijl, L.A., Clark, L.N., Wright, T.J., Dauwerse, H.G., Gruter, A.M., Hofker, M.H., Moerer, P., Williamson, R. et al. (1992) Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet., 2, 26-30.
6. van Deutekom, J.C., Wijmenga, C., van Tienhoven, E.A., Gruter, A.M., Hewitt, J.E., Padberg, G.W., van Ommen, G.J., Hofker, M.H., and Frants, R.R. (1993) FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet., 2, 2037-2042.
7. Lemmers, R.J., Tawil, R., Petek, L.M., Balog, J., Block, G.J., Santen, G.W., Amell, A.M., van der Vliet, P.J., Almomani, R., Straasheijm, K.R. et al. (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat. Genet., 44, 1370-1374.
8. Gabriels, J., Beckers, M.C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S.M., Padberg, G.W., Frants, R.R., Hewitt, J.E., Collen, D. et al. (1999) Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene, 236, 25-32.
9. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Matteotti, C., van Acker, A.M., Leo, O. et al. (2007) DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. U.S.A., 104, 18157-18162.
10. Snider, L., Geng, L.N., Lemmers, R.J., Kyba, M., Ware, C.B., Nelson, A.M., Tawil, R., Filippova, G.N., van der Maarel, S.M., Tapscott, S.J. et al. (2010) Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181.
11. Jones, T.I., Chen, J.C., Rahimov, F., Homma, S., Arashiro, P., Beermann, M.L., King, O.D., Miller, J.B., Kunkel, L.M., Emerson, C.P. Jr et al. (2012) Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum. Mol. Genet., 21, 4419-4430.
12. Rickard, A.M., Petek, L.M., and Miller, D.G. (2015) Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways. Hum. Mol. Genet., 24, 5901-5914.
13. Lemmers, R.J., van der Vliet, P.J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J.G., Snider, L., Straasheijm, K.R., van Ommen, G.J., Padberg, G.W. et al. (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science, 329, 1650-1653.
14. Bosnakovski, D., Xu, Z., Gang, E.J., Galindo, C.L., Liu, M., Simsek, T., Garner, H.R., Agha-Mohammadi, S., Tassin, A., Coppee, F. et al. (2008) An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-Associated molecular pathologies. EMBO J., 27, 2766-2779.
15. Geng, L.N., Yao, Z., Snider, L., Fong, A.P., Cech, J.N., Young, J.M., van der Maarel, S.M., Ruzzo, W.L., Gentleman, R.C., Tawil, R. et al. (2012) DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell, 22, 38-51.
16. Zhang, Y., Lee, J.K., Toso, E.A., Lee, J.S., Choi, S.H., Slattery, M., Aihara, H., and Kyba, M. (2016) DNA-binding sequence specificity of DUX4. Skeletal Muscle, 6, 8.
17. Clapp, J., Mitchell, L.M., Bolland, D.J., Fantes, J., Corcoran, A.E., Scotting, P.J., Armour, J.A., and Hewitt, J.E. (2007) Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet., 81, 264-279.
18. Kawamura-Saito, M., Yamazaki, Y., Kaneko, K., Kawaguchi, N., Kanda, H., Mukai, H., Gotoh, T., Motoi, T., Fukayama, M., Aburatani, H. et al. (2006) Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum. Mol. Genet., 15, 2125-2137.
19. Bosnakovski, D., Lamb, S., Simsek, T., Xu, Z., Belayew, A., Perlingeiro, R., and Kyba, M. (2008) DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp. Neurol., 214, 87-96.
20. Roeder, R.G. (2005) Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett., 579, 909-915.
21. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
22. Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science, 295, 868-872.
23. Iacovino, M., Bosnakovski, D., Fey, H., Rux, D., Bajwa, G., Mahen, E., Mitanoska, A., Xu, Z., and Kyba, M. (2011) Inducible cassette exchange: a rapid and efficient system enabling conditional gene expression in embryonic stem and primary cells. Stem Cells, 29, 1580-1588.
24. Zhang, L., Magli, A., Catanese, J., Xu, Z., Kyba, M., and Perlingeiro, R.C. (2011) Modulation of TGF-beta signaling by endoglin in murine hemangioblast development and primitive hematopoiesis. Blood, 118, 88-97.
25. Stols, L., Zhou, M., Eschenfeldt, W.H., Millard, C.S., Abdullah, J., Collart, F.R., Kim, Y., and Donnelly, M.I. (2007) New vectors for co-expression of proteins: structure of Bacillus subtilis ScoAB obtained by high-Throughput protocols. Protein Expr. Purif., 53, 396-403.
26. Zhu, C.H., Mouly, V., Cooper, R.N., Mamchaoui, K., Bigot, A., Shay, J.W., Di Santo, J.P., Butler-Browne, G.S., and Wright, W.E. (2007) Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell, 6, 515-523.
27. Agha-Mohammadi, S., O'Malley, M., Etemad, A., Wang, Z., Xiao, X., and Lotze, M.T. (2004) Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J .Gene Med., 6, 817-828.
28. Huber, W., Carey, V.J., Gentleman, R., Anders, S., Carlson, M., Carvalho, B.S., Bravo, H.C., Davis, S., Gatto, L., Girke, T. et al. (2015) Orchestrating high-Throughput genomic analysis with Bioconductor. Nat. Methods, 12, 115-121.
29. Love, M.I., Huber, W., and Anders, S. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 550.
30. Dandapat, A., Bosnakovski, D., Hartweck, L.M., Arpke, R.W., Baltgalvis, K.A., Vang, D., Baik, J., Darabi, R., Perlingeiro, R.C., Hamra, F.K. et al. (2014) Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene. Cell Rep., 8, 1484-1496.
31. Jin, Q., Yu, L.R., Wang, L., Zhang, Z., Kasper, L.H., Lee, J.E., Wang, C., Brindle, P.K., Dent, S.Y., and Ge, K. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J., 30, 249-262.
32. Krom, Y.D., Thijssen, P.E., Young, J.M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., Zammit, P.S. et al. (2013) Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet. 9, e1003415.
33. Tang, Z., Chen, W.Y., Shimada, M., Nguyen, U.T., Kim, J., Sun, X.J., Sengoku, T., McGinty, R.K., Fernandez, J.P., Muir, T.W. et al. (2013) SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell, 154, 297-310.
34. Tawil, R., van der Maarel, S.M., and Tapscott, S.J. (2014) Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skeletal Muscle, 4, 12.
35. Moellering, R.E., Cornejo, M., Davis, T.N., Del Bianco, C., Aster, J.C., Blacklow, S.C., Kung, A.L., Gilliland, D.G., Verdine, G.L., and Bradner, J.E. (2009) Direct inhibition of the NOTCH transcription factor complex. Nature, 462, 182-188.